| Autor: |
Jagasia, Madan, Salhotra, Amandeep, Bachier, Carlos R., Essell, James, Weisdorf, Daniel J., Zoghi, Behyar, Green, Laurie S., Schueller, Olivier, Zanin-Zhorov, Alexandra, Weiss, Jonathan M., Eiznhamer, David, Aggarwal, Sanjay K., Blazar, Bruce R., Lee, Stephanie J. |
| Zdroj: |
Blood; November 2018, Vol. 132 Issue: Supplement 1 p602-602, 1p |
| Abstrakt: |
Jagasia: Incyte Corporation: Membership on an entity's Board of Directors or advisory committees. Salhotra:Kadmon Corporation, LLC: Consultancy. Bachier:Sanofi: Speakers Bureau; Seattle Genetics: Speakers Bureau. Weisdorf:Seattle Genetics: Consultancy; Pharmacyclics: Consultancy; Equillium: Consultancy; SL Behring: Consultancy; FATE: Consultancy. Green:Kadmon Corporation, LLC: Employment. Schueller:Kadmon Corporation, LLC: Employment. Zanin-Zhorov:Kadmon Corporation, LLC: Employment. Weiss:Kadmon Corporation, LLC: Employment. Eiznhamer:Kadmon Corporation, LLC: Employment. Aggarwal:Kadmon Corporation, LLC: Employment. Blazar:Kadmon Corporation, LLC: Consultancy, Research Funding. Lee:Takeda: Research Funding; Kadmon: Research Funding; Amgen: Consultancy, Research Funding; Mallinckrodt: Honoraria; Incyte: Consultancy; Pfizer: Consultancy; Onyx: Research Funding. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
